The Patent Finder

Terms ending in 2031

Abraxis Bioscience, LLC

Every in-force patent on Abraxis Bioscience, LLC's record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 9,370,494Methods for Treating Hepatocellular Carcinoma
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 9,820,949Methods of Treatment of Pancreatic Cancer
In force
 · Medium confidence
Abraxis Bioscience, LLCIn forceMedium confidence
US 10,660,965Methods of Enhancing Drug Delivery and Effectiveness of Therapeutic Agents
In force
 · High confidence
Abraxis Bioscience, LLPIn forceHigh confidence
US 9,399,071Methods of Treatment of Pancreatic Cancer
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 9,399,072Methods of Treatment of Pancreatic Cancer
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited